Dominic Eisinger
Direttore/Membro del Consiglio presso BioFactura, Inc.
Profilo
Dominic Eisinger is the founder of Multiplex Biosciences, Inc., which was founded in 2000.
He held the title of President & Director-Business Development in 2006.
Dr. Eisinger is currently working as a Director at BioFactura, Inc. and as a Vice President-Sales & Marketing at Myriad RBM, Inc.
Posizioni attive di Dominic Eisinger
| Società | Posizione | Inizio |
|---|---|---|
Myriad RBM, Inc.
 Myriad RBM, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad RBM, Inc. provides protein biomarker products and services. Its biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. The company was founded in 1998 and is headquartered in Salt Lake City, UT. | Vendite & Marketing | - |
BioFactura, Inc.
 BioFactura, Inc. Pharmaceuticals: MajorHealth Technology BioFactura, Inc. develops and manufactures high-value biosimilars, biodefense medical countermeasures, and client-selected novel drugs. It also specializes in developing and performing in-process and release analytical assays including HPLC methods, SDS-PAGE and Western analysis, antibody/antigen capture ELISAs, and bioactivity methods. The company was founded by Darryl Sampey and Alexandre DeSeabra in 2004 and is headquartered in Frederick, MD. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Dominic Eisinger
| Società | Posizione | Fine |
|---|---|---|
Multiplex Biosciences, Inc.
 Multiplex Biosciences, Inc. Medical/Nursing ServicesHealth Services Multiplex Biosciences, Inc. provides contract multiplex immunoassay development, validation, and manufacturing services to pharmaceutical companies, biotech firms, and academic research institutions. The company is based in Lake Placid, NY. The company was founded by Dominic Eisinger. Multiplex Biosciences was acquired by Myriad RBM, Inc., part of Q2 Solutions from July 01, 2021 on November 15, 2006. | Fondatore | 01/01/2006 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Myriad RBM, Inc.
Myriad RBM, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad RBM, Inc. provides protein biomarker products and services. Its biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. The company was founded in 1998 and is headquartered in Salt Lake City, UT. | Commercial Services |
Multiplex Biosciences, Inc.
Multiplex Biosciences, Inc. Medical/Nursing ServicesHealth Services Multiplex Biosciences, Inc. provides contract multiplex immunoassay development, validation, and manufacturing services to pharmaceutical companies, biotech firms, and academic research institutions. The company is based in Lake Placid, NY. The company was founded by Dominic Eisinger. Multiplex Biosciences was acquired by Myriad RBM, Inc., part of Q2 Solutions from July 01, 2021 on November 15, 2006. | Health Services |
BioFactura, Inc.
BioFactura, Inc. Pharmaceuticals: MajorHealth Technology BioFactura, Inc. develops and manufactures high-value biosimilars, biodefense medical countermeasures, and client-selected novel drugs. It also specializes in developing and performing in-process and release analytical assays including HPLC methods, SDS-PAGE and Western analysis, antibody/antigen capture ELISAs, and bioactivity methods. The company was founded by Darryl Sampey and Alexandre DeSeabra in 2004 and is headquartered in Frederick, MD. | Health Technology |
- Borsa valori
- Insiders
- Dominic Eisinger
